Wednesday, June 10, 2015

The BMJ weighs in on Avastin/Lucentis debate -

The BMJ weighs in on Avastin/Lucentis debate - PMLiVE

www.pmlive.com › pharma_news › the_...
Mobile-friendly - Apr 2, 2015 - Currently, General Medical Council guidance and European drug licensing laws say that Lucentis (ranibizumab)

No comments: